Oseltamivir Phosphate
Product Images NDC 67296-1725

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oseltamivir Phosphate (NDC 67296-1725). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (A1279325 8446 412f 83b1 46ed6c5666c0 01)

Chemical structure diagram depicting the molecular structure of Oseltamivir Phosphate. The diagram includes labeled atoms and bonds representing the compound's detailed chemical arrangement as submitted in the FDA Structured Product Labeling for RedPharm Drug's Oseltamivir Phosphate.*

FDA Label Image

Principal Display Panel (Carton-30)

Packaging label for Oseltamivir Phosphate Capsules, USP 30 mg, displaying a quantity of 10 capsules (1x10 unit-dose). The label shows the product name, strength, dosage form, and manufacturer Strides Pharma Inc. It includes barcodes, storage instructions, and distributor information for Strides Pharma Inc., East Brunswick, NJ. The label design features a pink and white color scheme with black text.*

FDA Label Image

Principal Display Panel (Carton-45mg)

Packaging label for Oseltamivir Phosphate Capsules, USP 45 mg by Strides Pharma Inc. The label shows a box containing 10 capsules (1x10 unit-dose). It includes storage instructions, manufacturer Strides Pharma Science Limited (India), and distributor Strides Pharma Inc. (New Jersey). The label features usage dosage advice and barcodes, with a purple and white color scheme.*

FDA Label Image

Principal Display Panel (Carton-75mg)

Packaging label for Oseltamivir Phosphate Capsules, USP 75 mg. The label shows a box design for a 10-capsule supply (1 x 10 unit-dose). It includes the manufacturer Strides Pharma Inc. and distributor Strides Pharma Inc. with locations in India and New Jersey, respectively. The label displays dosage form, strength, NDC 64380-799-01, and storage instructions.*

FDA Label Image

Principal Display Panel (30 mg foil)

A sheet of multiple Oseltamivir Phosphate labels from RedPharm Drug, each with barcode and product information. The labels are arranged in a grid, showing the proprietary name Oseltamivir Phosphate and instructions to peel and open. The sheet layout suggests these labels are for packaging or product identification use.*

FDA Label Image

Principal Display Panel (45 mg foil)

Sheet of multiple barcode labels for Oseltamivir Phosphate capsules, USP 45 mg from RedPharm Drug. Each label includes the product name, strength, dosage form, labeler name, and a barcode. The labels are arranged in rows and columns on a single printable sheet.*

FDA Label Image

Principal Display Panel (75 mg foil)

Multiple identical blister labels for Oseltamivir Phosphate capsules, strength of 75 mg, from RedPharm Drug. Each label includes the product name, capsule indication, barcodes, and instructions to peel to open. The labels are arranged in rows on a sheet with perforation marks visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.